Table 2.
Analysis of association between FMD and some relevant parameters by univariate and multivariate linear regression in baseline.
| Univariate Rho (p) | Multivariate Beta (p) | |
|---|---|---|
| Baseline data (r2 = 0.74) | ||
| ADMA (µmol/l) | −0.78 (<0.001) | −0.38 (<0.001) |
| Malondialdehyde (MDA) (nmol/ml) | −0.68 (<0.001) | NS |
| CuZn-SOD (U/ml) | 0.66 (<0.001) | 0.13 (0.01) |
| GSH-Px (U/ml) | 0.32 (<0.001) | NS |
| PTX3 (ng/ml) | −0.61 (<0.001) | −0.14 (0.01) |
| hs-CRP (mg/l) | −0.72 (0.02) | NS |
| eGFR (ml/min/ 1.73 m2) | 0.23 (0.001) | NS |
| Hemoglobin (g/dl) | 0.59 (<0.001) | 0.33 (<0.001) |
| Total Cholesterol (mg/dl) | −0.51 (<0.001) | NS |
| Triglyceride (mg/dl) | −0.17 (<0.001) | NS |
| LDL cholesterol (mg/dl) | −0.27 (<0.001) | NS |
| HDL cholesterol (mg/dl) | 0.13 (0.05) | NS |
| Systolic blood pressure (mmHg) | −0.59 (<0.001) | −0.13 (0.004) |
| Diastolic blood pressure (mmHg) | −0.27 (<0.001) | NS |
| Serum albumin (g/dl) | 0.08 (0.23) | NS |
| HOMA-IR | −0.29 (<0.001) | NS |
| HbA1c (%) | −0.54 (<0.001) | NS |
ADMA: Asymmetric dimethyl arginine; HOMA, homeostasis model assessment; eGFR, estimated glomerular filtration rate; hsCRP, high sensitivity C reactive protein; PTX3, pentraxin 3; CuZn-SOD, copper zinc-superoxide dismutase; GSH-Px, glutathione peroxidase; MDA, Malondialdehyde.